| High daily dosage | Early refills | Overlapping prescriptions | Multiple providers | |
| N (%) with outcome | 317 (10.2) | 1,121 (35.9) | 772 (24.7) | 938 (30.0) |
| Incidence rate per 100 PY | 5.9 | 31.4 | 10.1 | 23.3 |
| Median years to first occurrence | Undefined | 2.57 | Undefined | 3.38 |
| Multivariable Cox regression model, Hazard Ratio (95% CI) | ||||
| Age 18-34 | Ref | Ref | Ref | Ref |
| Age 35-44 | 1.89 (1.20-2.98) | 1.68 (1.35-2.09) | 1.36 (1.06-1.74) | 1.25 (1.00-1.56) |
| Age 45-65 | 1.86 (1.17-2.95) | 1.73 (1.39-2.17) | 1.42 (1.10-1.83) | 1.14 (0.91-1.43) |
| Male sex | 0.92 (0.72-1.18) | 1.24 (1.08-1.42) | 0.87 (0.74-1.01) | 1.12 (0.97-1.30) |
| IDU as HIV risk factor | 1.45 (1.13-1.86) | 1.37 (1.20-1.57) | 1.45 (1.23-1.71) | 1.31 (1.13-1.52) |
| Depression diagnosis | 1.02 (0.80-1.31) | 1.05 (0.92-1.20) | 1.01 (0.86-1.18) | 0.98 (0.85-1.13) |
| Chronic pain diagnosis | 1.71 (1.34-2.18) | 1.34 (1.18-1.54) | 1.72 (1.47-2.02) | 1.35 (1.17-1.56) |